ANGPT4 and neoplasm: Angiopoietins, including ANGPT1, ANGPT2, and ANGPT4, have been reported to act as ligands of the tyrosine kinase receptors TIE1 and TIE2 to activate MAPK signaling pathways during tumor angiogenesis in mammals (Huang et al., 2010).